USPH:NYE-U.S. Physical Therapy Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 100.61

Change

+0.23 (+0.23)%

Market Cap

USD 0.78B

Volume

0.03M

Analyst Target

USD 89.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

US Physical Therapy Inc operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, and rehabilitation of injured workers among others.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-5.03 (-1.60%)

USD 80.70B
UHS Universal Health Services Inc

-0.03 (-0.02%)

USD 11.68B
DVA DaVita HealthCare Partners Inc

-1.84 (-1.34%)

USD 11.67B
FMS Fresenius Medical Care Corpora..

+0.57 (+2.83%)

USD 11.00B
THC Tenet Healthcare Corporation

-1.23 (-0.99%)

USD 10.22B
CHE Chemed Corp

-7.65 (-1.32%)

USD 9.53B
EHC Encompass Health Corp

-0.59 (-0.69%)

USD 8.26B
SEM Select Medical Holdings

+0.11 (+0.34%)

USD 3.87B
AMN AMN Healthcare Services Inc

+0.08 (+0.13%)

USD 2.28B
AGL agilon health Inc

+0.21 (+4.22%)

USD 2.05B

ETFs Containing USPH

RNSC First Trust Small Cap US .. 2.59 % 0.60 %

-0.01 (-0.05%)

USD 0.03B
DESC 0.00 % 0.30 %

N/A

N/A
EWX SPDR® S&P Emerging Marke.. 0.00 % 0.65 %

-0.09 (-0.05%)

USD 0.84B
FEMS First Trust Emerging Mark.. 0.00 % 0.80 %

-0.19 (-0.05%)

USD 0.32B
GVAL 0.00 % 0.69 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.02% 48% F 78% C+
Dividend Return 0.47% 71% C- 27% F
Total Return 8.49% 52% F 77% C+
Trailing 12 Months  
Capital Gain -5.50% 52% F 25% F
Dividend Return 1.63% 63% D 23% F
Total Return -3.87% 52% F 21% F
Trailing 5 Years  
Capital Gain -14.29% 27% F 32% F
Dividend Return 5.49% 43% F 18% F
Total Return -8.80% 27% F 22% F
Average Annual (5 Year Horizon)  
Capital Gain 0.08% 39% F 40% F
Dividend Return 1.31% 39% F 34% F
Total Return 1.23% 63% D 30% F
Risk Return Profile  
Volatility (Standard Deviation) 27.39% 74% C 41% F
Risk Adjusted Return 4.78% 43% F 30% F
Market Capitalization 0.78B 58% F 61% D-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 32.40 5% 7%
Price/Book Ratio 3.37 36% 26%
Price / Cash Flow Ratio 19.37 13% 17%
Price/Free Cash Flow Ratio 22.99 8% 11%
Management Effectiveness  
Return on Equity 6.55% 55% 44%
Return on Invested Capital 10.23% 71% 65%
Return on Assets 4.69% 67% 70%
Debt to Equity Ratio 29.19% 73% 73%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.